NuVasive, Inc. (NUVA) - NASDAQ
  • Tue, Jan. 5, 4:36 PM
    • NuVasive (NASDAQ:NUVA) acquires privately held Ellipse Technologies for $380M cash upfront and a potential $30M milestone payable in 2017 related to specific revenue targets. NUVA expects the transaction to accelerate its top line growth in the high-single-digit range and be slightly accretive to its non-GAAP EPS in the first year and significantly accretive thereafter.
    • Ellipse develops devices used in orthopedic surgery. Its PRECICE device is an intramedullary nail used to lengthen the femur and tibia and MAGEC is a spinal bracing and distraction system.
    • NuVasive will host a conference call today at 5:00 pm ET to discuss the deal.
    | Tue, Jan. 5, 4:36 PM
  • Sep. 29, 2011, 11:28 AM

    Medical device company NuVasive (NUVA -9.4%) trades off today after it agrees to buy privately held Impulse Monitoring, a provider of monitoring services during surgeries, for $80M in cash and stock.

    | Sep. 29, 2011, 11:28 AM
Company Description
NuVasive, Inc. is a medical device company, which is focused on the design, development, and market of surgical products to treat the spine. Its products include a minimally disruptive surgical platform called Maximum Access Surgery, in addition to biologics, cervical and motion preservation... More
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: United States